Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications
MedComm · 2025-02 · 6 (2)
DOI: 10.1002/mco2.70056 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 16.01.2025. Verfasst von Ming Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Vaccines for Infectious Diseases National Institute of Diagnostics and Vaccine Development in Infectious Diseases Xiang An Bi…. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Rapid advances in vaccine technology are becoming increasingly important in tackling global health crises caused by respiratory virus infections. While traditional vaccines, primarily administered by intramuscular injection, have proven effective, they often fail to provide the broad upper respiratory tract mucosal immunity, which is urgently needed for first‐line control of respiratory viral infections. Furthermore, traditional intramuscular vaccines may not adequately address the immune escape of emerging virus variants. In contrast, respiratory mucosal vaccines developed using the body's mucosal immune response mechanism can simultaneously establish both systemic and mucosal immunity. This dual action effectively allows the respiratory mucosal immune system to function as the first line of defense, preventing infections at the entry points. This review highlights the efficacy of respiratory mucosal vaccines, including innovative delivery methods such as nasal and oral formulations, in enhancing local and systemic immune barriers. Notably, respiratory mucosal vaccines offer potential advantages in protecting against emerging virus variants and maintaining long‐term and multidimensional immune memory in the upper respiratory tract. In addition, a combination of intramuscular and respiratory mucosal delivery of vaccines largely improves their coverage and effectiveness, providing valuable insights for future vaccine development and public inoculation strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Vaccines for Infectious Diseases National Institute of Diagnostics and Vaccine Development in Infectious Diseases Xiang An Biomedicine Laboratory School of Life Sciences & School of Public Health…
ORCID-Profile: Lunzhi Yuan
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Zhou, M., Xiao, H., Yang, X., Cheng, T., Yuan, L., & Xia, N. (2025). Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications. MedComm, 6(2). https://doi.org/10.1002/mco2.70056
Vancouver
Zhou M, Xiao H, Yang X, Cheng T, Yuan L, Xia N. Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications. MedComm. 2025;6(2). doi:10.1002/mco2.70056
BibTeX
@article{Zhou2025,
author = {Zhou, Ming and Xiao, Haiqin and Yang, Xinyi and Cheng, Tong and Yuan, Lunzhi and Xia, Ningshao},
title = {Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications},
journal = {MedComm},
year = {2025},
volume = {6},
number = {2},
doi = {10.1002/mco2.70056}
}
EUVIMED